🚀 VC round data is live in beta, check it out!
Shoulder Innovations Valuation Multiples
Discover revenue and EBITDA valuation multiples for Shoulder Innovations and similar public comparables like Zepp Health, TriSalus Life Sciences, Eurobio Scientific, Sight Sciences and more.
Shoulder Innovations Overview
About Shoulder Innovations
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
Founded
2009
HQ
Employees
56
Website
Sectors
Financials (LTM)
EV
$156M
Shoulder Innovations Financials
Shoulder Innovations reported last 12-month revenue of $52M and negative EBITDA of ($34M).
In the same LTM period, Shoulder Innovations generated $40M in gross profit, ($34M) in EBITDA losses, and had net loss of ($39M).
Revenue (LTM)
Shoulder Innovations P&L
In the most recent fiscal year, Shoulder Innovations reported revenue of $47M and EBITDA of ($36M).
Shoulder Innovations expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $52M | XXX | $47M | XXX | XXX | XXX |
| Gross Profit | $40M | XXX | $36M | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 77% | XXX | XXX | XXX |
| EBITDA | ($34M) | XXX | ($36M) | XXX | XXX | XXX |
| EBITDA Margin | (66%) | XXX | (77%) | XXX | XXX | XXX |
| EBIT Margin | (55%) | XXX | (56%) | XXX | XXX | XXX |
| Net Profit | ($39M) | XXX | ($40M) | XXX | XXX | XXX |
| Net Margin | (75%) | XXX | (85%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Shoulder Innovations Stock Performance
Shoulder Innovations has current market cap of $279M, and enterprise value of $156M.
Market Cap Evolution
Shoulder Innovations' stock price is $13.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $156M | $279M | 0.0% | XXX | XXX | XXX | $-1.96 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShoulder Innovations Valuation Multiples
Shoulder Innovations trades at 3.0x EV/Revenue multiple, and (4.6x) EV/EBITDA.
EV / Revenue (LTM)
Shoulder Innovations Financial Valuation Multiples
As of March 29, 2026, Shoulder Innovations has market cap of $279M and EV of $156M.
Equity research analysts estimate Shoulder Innovations' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Shoulder Innovations has a P/E ratio of (7.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $279M | XXX | $279M | XXX | XXX | XXX |
| EV (current) | $156M | XXX | $156M | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBITDA | (4.6x) | XXX | (4.3x) | XXX | XXX | XXX |
| EV/EBIT | (5.6x) | XXX | (5.9x) | XXX | XXX | XXX |
| EV/Gross Profit | 3.9x | XXX | 4.3x | XXX | XXX | XXX |
| P/E | (7.2x) | XXX | (6.9x) | XXX | XXX | XXX |
| EV/FCF | (4.3x) | XXX | (4.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shoulder Innovations Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Shoulder Innovations Margins & Growth Rates
Shoulder Innovations' revenue in the last 12 month grew by 35%.
Shoulder Innovations' revenue per employee in the last FY averaged $0.9M.
Shoulder Innovations' rule of 40 is (30%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shoulder Innovations' rule of X is 23% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Shoulder Innovations Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 35% | XXX | 38% | XXX | XXX | XXX |
| EBITDA Margin | (66%) | XXX | (77%) | XXX | XXX | XXX |
| EBITDA Growth | (27%) | XXX | (27%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (30%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 17% | XXX | 16% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 132% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Shoulder Innovations Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Zepp Health | XXX | XXX | XXX | XXX | XXX | XXX |
| TriSalus Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Eurobio Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Sight Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Stratec | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shoulder Innovations M&A Activity
Shoulder Innovations acquired XXX companies to date.
Last acquisition by Shoulder Innovations was on XXXXXXXX, XXXXX. Shoulder Innovations acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Shoulder Innovations
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialShoulder Innovations Investment Activity
Shoulder Innovations invested in XXX companies to date.
Shoulder Innovations made its latest investment on XXXXXXXX, XXXXX. Shoulder Innovations invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Shoulder Innovations
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shoulder Innovations
| When was Shoulder Innovations founded? | Shoulder Innovations was founded in 2009. |
| Where is Shoulder Innovations headquartered? | Shoulder Innovations is headquartered in United States. |
| How many employees does Shoulder Innovations have? | As of today, Shoulder Innovations has over 56 employees. |
| Is Shoulder Innovations publicly listed? | Yes, Shoulder Innovations is a public company listed on NYSE. |
| What is the stock symbol of Shoulder Innovations? | Shoulder Innovations trades under SI ticker. |
| When did Shoulder Innovations go public? | Shoulder Innovations went public in 2025. |
| Who are competitors of Shoulder Innovations? | Shoulder Innovations main competitors are Zepp Health, TriSalus Life Sciences, Eurobio Scientific, Sight Sciences. |
| What is the current market cap of Shoulder Innovations? | Shoulder Innovations' current market cap is $279M. |
| What is the current revenue of Shoulder Innovations? | Shoulder Innovations' last 12 months revenue is $52M. |
| What is the current revenue growth of Shoulder Innovations? | Shoulder Innovations revenue growth (NTM/LTM) is 35%. |
| What is the current EV/Revenue multiple of Shoulder Innovations? | Current revenue multiple of Shoulder Innovations is 3.0x. |
| Is Shoulder Innovations profitable? | No, Shoulder Innovations is not profitable. |
| What is the current EBITDA of Shoulder Innovations? | Shoulder Innovations has negative EBITDA and is not profitable. |
| What is Shoulder Innovations' EBITDA margin? | Shoulder Innovations' last 12 months EBITDA margin is (66%). |
| What is the current EV/EBITDA multiple of Shoulder Innovations? | Current EBITDA multiple of Shoulder Innovations is (4.6x). |
| What is the current FCF of Shoulder Innovations? | Shoulder Innovations' last 12 months FCF is ($37M). |
| What is Shoulder Innovations' FCF margin? | Shoulder Innovations' last 12 months FCF margin is (71%). |
| What is the current EV/FCF multiple of Shoulder Innovations? | Current FCF multiple of Shoulder Innovations is (4.3x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.